Ho P Michael, Glorioso Thomas J, Allen Larry A, Blankenhorn Richard, Glasgow Russell E, Grunwald Gary K, Khanna Amber, Magid David J, Marrs Joel C, Novins-Montague Sylvie, Orlando Steven, Peterson Pamela, Plomondon Mary E, Sandy Lisa M, Saseen Joseph J, Trinkley Katy E, Vaughn Shawni, Waughtal Joy, Bull Sheana
Rocky Mountain Regional Veteran Affairs Medical Center, Aurora, Colorado.
Division of Cardiology, University of Colorado School of Medicine, Aurora.
JAMA. 2025 Jan 7;333(1):49-59. doi: 10.1001/jama.2024.21739.
Poor medication adherence is common. Text messaging is increasingly used to change patient behavior but often not rigorously tested.
To compare different types of text messaging strategies with usual care to improve medication refill adherence among patients nonadherent to cardiovascular medications.
DESIGN, SETTING, AND PARTICIPANTS: Patient-level randomized pragmatic trial between October 2019 to April 2022 at 3 US health care systems, with last follow-up date of April 11, 2023. Adult (18 to <90 years) patients were eligible based on diagnosis of 1 or more cardiovascular condition(s) and prescribed medication to treat the condition. Patients who did not opt out and had a 7-day refill gap were randomized to 1 of 4 study groups.
INTERVENTION(S): Generic text message refill reminders (generic reminder); behavioral nudge text refill reminders (behavioral nudge); behavioral nudge text refill reminders plus a fixed-message chatbot (behavioral nudge + chatbot); usual care.
Primary outcome was refill adherence based on pharmacy data using proportion of days covered at 12 months. Secondary outcomes were clinical events of emergency department visits, hospitalizations, and mortality.
Among 9501 enrolled patients, baseline characteristics across the 4 groups were comparable (mean age, 60 years; 47% female [n = 4351]; 16% Black [n = 1517]; 49% Hispanic [n = 4564]). At 12 months, the mean proportion of days covered was 62.0% for generic reminder, 62.3% for behavioral nudge, 63.0% for behavioral nudge + chatbot, and 60.6% for usual care (P = .06). In adjusted analysis, when compared with usual care, mean proportion of days covered was 2.2 percentage points (95% CI, 0.3-4.2; P = .02) higher for generic reminder, 2.0 percentage points (95% CI, 0.1-3.9; P = .04) higher for behavioral nudge, and 2.3 percentage points (95%, 0.4-4.2; P = .02) higher for behavioral nudge + chatbot, none of which were statistically significant after multiple comparisons correction. There were no differences in clinical events between study groups.
Text message reminders targeting patients who delay refilling their cardiovascular medications did not improve medication adherence based on pharmacy refill data or reduce clinical events at 12 months. Poor medication adherence may be due to multiple factors. Future interventions may need to be designed to address the multiple factors influencing adherence.
ClinicalTrials.gov Identifier: NCT03973931.
药物治疗依从性差很常见。短信越来越多地用于改变患者行为,但往往未经严格测试。
比较不同类型的短信策略与常规护理,以提高心血管药物治疗依从性差的患者的药物续方依从性。
设计、设置和参与者:2019年10月至2022年4月在美国3个医疗系统进行的患者层面随机实用试验,最后随访日期为2023年4月11日。成年(18至<90岁)患者基于诊断出1种或更多心血管疾病且开具了治疗该疾病的药物而符合条件。未选择退出且有7天续方间隔的患者被随机分配到4个研究组中的1组。
通用短信续方提醒(通用提醒);行为助推短信续方提醒(行为助推);行为助推短信续方提醒加固定信息聊天机器人(行为助推+聊天机器人);常规护理。
主要结局是基于药房数据的续方依从性,采用12个月的覆盖天数比例。次要结局是急诊科就诊、住院和死亡的临床事件。
在9501名登记患者中,4组的基线特征具有可比性(平均年龄60岁;47%为女性[n = 4351];16%为黑人[n = 1517];49%为西班牙裔[n = 4564])。在12个月时,通用提醒组的平均覆盖天数比例为62.0%,行为助推组为62.3%,行为助推+聊天机器人组为63.0%,常规护理组为60.6%(P = 0.06)。在调整分析中,与常规护理相比,通用提醒组的平均覆盖天数比例高2.2个百分点(95%置信区间,0.3 - 4.2;P = 0.02),行为助推组高2.0个百分点(95%置信区间,0.1 - 3.9;P = 0.04),行为助推+聊天机器人组高2.3个百分点(95%,0.4 - 4.2;P = 0.02),在多重比较校正后均无统计学意义。研究组之间的临床事件无差异。
针对延迟心血管药物续方的患者的短信提醒,基于药房续方数据并未改善药物依从性,也未在12个月时减少临床事件。药物依从性差可能是由于多种因素。未来的干预措施可能需要设计用于解决影响依从性的多种因素。
ClinicalTrials.gov标识符:NCT03973931。